Skip to main content

ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease

Safety and Effectiveness of STSF Catheter Evaluated for Treating Symptomatic Persistent Atrial Fibrillation (PsAF)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Safety and Effectiveness of STSF Catheter Evaluated for Treating Symptomatic Persistent Atrial Fibrillation (PsAF)

Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)

Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D)

Phase I Trial of BAY1251152 for Advanced Blood Cancers

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Phase I Trial of BAY1251152 for Advanced Blood Cancers

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

Study of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & Neck

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Study of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & Neck

Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia

A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 106
  • Page 107
  • Page 108
  • Page 109
  • Page 110
  • Page 111
  • Page 112
  • Page 113
  • Page 114
  • …
  • Next page Next
  • Last page Last
Subscribe to